1178 related articles for article (PubMed ID: 19750747)
1. Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease.
Steele JL; Henik RA; Stepien RL
Vet Ther; 2002; 3(2):157-66. PubMed ID: 19750747
[TBL] [Abstract][Full Text] [Related]
2. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
Jensen J; Henik RA; Brownfield M; Armstrong J
Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
[TBL] [Abstract][Full Text] [Related]
3. Effect of enalapril on blood pressure, renal function, and the renin-angiotensin-aldosterone system in cats with autosomal dominant polycystic kidney disease.
Miller RH; Lehmkuhl LB; Smeak DD; DiBartola SP; Radin J
Am J Vet Res; 1999 Dec; 60(12):1516-25. PubMed ID: 10622161
[TBL] [Abstract][Full Text] [Related]
4. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
[TBL] [Abstract][Full Text] [Related]
5. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
[TBL] [Abstract][Full Text] [Related]
6. Enalaprilat: an intravenous substitute for oral enalapril therapy. Humoral and pharmacokinetic effects.
Reams GP; Lal SM; Whalen JJ; Bauer JH
J Clin Hypertens; 1986 Sep; 2(3):245-53. PubMed ID: 3023555
[TBL] [Abstract][Full Text] [Related]
7. Dual blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy: the role of aldosterone.
Schjoedt KJ; Jacobsen P; Rossing K; Boomsma F; Parving HH
Horm Metab Res; 2005 Apr; 37 Suppl 1():4-8. PubMed ID: 15918104
[TBL] [Abstract][Full Text] [Related]
8. Does lipophilicity of angiotensin converting enzyme inhibitors selectively influence autonomic neural function in human hypertension?
Wu RA; Kailasam MT; Cervenka JH; Parmer RJ; Kennedy BP; Ziegler MG; O'Connor DT
J Hypertens; 1994 Nov; 12(11):1243-7. PubMed ID: 7868871
[TBL] [Abstract][Full Text] [Related]
9. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
Abassi Z; Armaly Z; Nakhoul F; Hoffman A
Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
[TBL] [Abstract][Full Text] [Related]
10. Physiological effects of short-term treatment with enalapril in hypertensive patients.
de Leeuw PW; Hoogma RP; van Soest GA; van Es PN; Birkenhäger WH
J Hypertens Suppl; 1983 Oct; 1(1):87-91. PubMed ID: 6100612
[TBL] [Abstract][Full Text] [Related]
11. A dynamic comparative study concerning the effects of angiotensin-converting enzyme inhibitors and aldosterone receptor blockers on the fibrinolytic system.
Usalan C; Buyukhatipoglu H
Clin Appl Thromb Hemost; 2008 Apr; 14(2):203-9. PubMed ID: 18372278
[TBL] [Abstract][Full Text] [Related]
12. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure.
Ligtenberg G; Blankestijn PJ; Oey PL; Klein IH; Dijkhorst-Oei LT; Boomsma F; Wieneke GH; van Huffelen AC; Koomans HA
N Engl J Med; 1999 Apr; 340(17):1321-8. PubMed ID: 10219067
[TBL] [Abstract][Full Text] [Related]
13. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension.
Jackson B; Cubela R; Johnston CI
J Hypertens; 1984 Aug; 2(4):371-7. PubMed ID: 6099390
[TBL] [Abstract][Full Text] [Related]
14. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
McCaa RE; Gillespie JB
Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
[TBL] [Abstract][Full Text] [Related]
15. Effects of raloxifene on the renin-angiotensin-aldosterone system and blood pressure in hypertensive and normotensive osteoporotic postmenopausal women.
Sumino H; Ichikawa S; Kasama S; Takahashi T; Kumakura H; Takayama Y; Kanda T; Murakami M; Kurabayashi M
Geriatr Gerontol Int; 2010 Jan; 10(1):70-7. PubMed ID: 20102385
[TBL] [Abstract][Full Text] [Related]
16. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease.
Chapman AB; Johnson A; Gabow PA; Schrier RW
N Engl J Med; 1990 Oct; 323(16):1091-6. PubMed ID: 2215576
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade.
Biollaz J; Brunner HR; Gavras I; Waeber B; Gavras H
J Cardiovasc Pharmacol; 1982; 4(6):966-72. PubMed ID: 6185790
[TBL] [Abstract][Full Text] [Related]
18. [Clinical pharmacology of enalapril in hypertension with chronic renal failure].
Chaignon M; Billaud-Mesguich E; Alexandre JM; Guédon J
Arch Mal Coeur Vaiss; 1986 Jun; 79(6):967-70. PubMed ID: 3026274
[TBL] [Abstract][Full Text] [Related]
19. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive activity of enalapril. Effect of ibuprofen and different salt intakes.
Minuz P; Lechi A; Arosio E; Degan M; Capuzzo MG; Lechi C; Corsato M; Dalla Riva A; Velo GP
J Clin Hypertens; 1987 Dec; 3(4):645-53. PubMed ID: 2839629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]